ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa05332	Graft-versus-host disease	3/73	42/8144	0.006175	0.7372	0.7372	IL2/IL1A/KLRC1	3
KEGG	hsa04151	PI3K-Akt signaling pathway	8/73	354/8144	0.01346	0.7372	0.7372	SGK2/TEK/IRS1/COL9A1/IL2/PHLPP2/IL2RB/SYK	8
KEGG	hsa04974	Protein digestion and absorption	4/73	103/8144	0.01349	0.7372	0.7372	PGA5/COL9A1/MEP1A/COL17A1	4
KEGG	hsa04612	Antigen processing and presentation	3/73	78/8144	0.03257	0.8498	0.8498	CD74/KLRC4/KLRC1	3
KEGG	hsa04940	Type I diabetes mellitus	2/73	43/8144	0.05653	0.8498	0.8498	IL2/IL1A	2
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	3/73	100/8144	0.06032	0.8498	0.8498	IL2/CCL21/IL2RB	3
KEGG	hsa04064	NF-kappa B signaling pathway	3/73	104/8144	0.06626	0.8498	0.8498	GADD45G/CCL21/SYK	3
KEGG	hsa04979	Cholesterol metabolism	2/73	50/8144	0.07371	0.8498	0.8498	APOC2/ANGPTL3	2
KEGG	hsa05202	Transcriptional misregulation in cancer	4/73	193/8144	0.09449	0.8498	0.8498	HHEX/GADD45G/IL2RB/FEV	4
KEGG	hsa05217	Basal cell carcinoma	2/73	63/8144	0.1092	0.8498	0.8498	FZD6/GADD45G	2
KEGG	hsa05203	Viral carcinogenesis	4/73	204/8144	0.11	0.8498	0.8498	ACTN1/PMAIP1/HDAC9/SYK	4
KEGG	hsa04068	FoxO signaling pathway	3/73	131/8144	0.1127	0.8498	0.8498	SGK2/IRS1/GADD45G	3
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	3/73	131/8144	0.1127	0.8498	0.8498	SH3BP2/KLRC1/SYK	3
KEGG	hsa05321	Inflammatory bowel disease	2/73	65/8144	0.115	0.8498	0.8498	IL2/IL1A	2
KEGG	hsa04060	Cytokine-cytokine receptor interaction	5/73	295/8144	0.1243	0.8498	0.8498	IL2/CNTF/IL1A/CCL21/IL2RB	5
KEGG	hsa05162	Measles	3/73	139/8144	0.1284	0.8498	0.8498	IL2/IL1A/IL2RB	3
KEGG	hsa04115	p53 signaling pathway	2/73	73/8144	0.139	0.8498	0.8498	GADD45G/PMAIP1	2
KEGG	hsa00120	Primary bile acid biosynthesis	1/73	17/8144	0.1421	0.8498	0.8498	ACOX2	1
KEGG	hsa05206	MicroRNAs in cancer	5/73	310/8144	0.1444	0.8498	0.8498	FOXP1/IRS1/TIMP3/MIR181A1/MIR181B1	5
KEGG	hsa05212	Pancreatic cancer	2/73	76/8144	0.1483	0.8498	0.8498	GADD45G/ARHGEF6	2
KEGG	hsa04146	Peroxisome	2/73	82/8144	0.1671	0.8498	0.8498	ACOX2/XDH	2
KEGG	hsa04630	JAK-STAT signaling pathway	3/73	162/8144	0.1772	0.8498	0.8498	IL2/CNTF/IL2RB	3
KEGG	hsa00340	Histidine metabolism	1/73	22/8144	0.1799	0.8498	0.8498	ALDH7A1	1
KEGG	hsa05210	Colorectal cancer	2/73	86/8144	0.1799	0.8498	0.8498	GADD45G/PMAIP1	2
KEGG	hsa04614	Renin-angiotensin system	1/73	23/8144	0.1873	0.8498	0.8498	CTSG	1
KEGG	hsa04530	Tight junction	3/73	169/8144	0.193	0.8498	0.8498	AMOTL1/ACTN1/CLDN20	3
KEGG	hsa04658	Th1 and Th2 cell differentiation	2/73	92/8144	0.1994	0.8498	0.8498	IL2/IL2RB	2
KEGG	hsa05323	Rheumatoid arthritis	2/73	93/8144	0.2027	0.8498	0.8498	TEK/IL1A	2
KEGG	hsa04950	Maturity onset diabetes of the young	1/73	26/8144	0.209	0.8498	0.8498	HHEX	1
KEGG	hsa05152	Tuberculosis	3/73	180/8144	0.2185	0.8498	0.8498	CD74/IL1A/SYK	3
KEGG	hsa04080	Neuroactive ligand-receptor interaction	5/73	362/8144	0.2236	0.8498	0.8498	CHRNA3/CTSG/GAL/MC3R/GNRH1	5
KEGG	hsa04916	Melanogenesis	2/73	101/8144	0.2291	0.8498	0.8498	FZD6/TYR	2
KEGG	hsa05146	Amoebiasis	2/73	102/8144	0.2324	0.8498	0.8498	CTSG/ACTN1	2
KEGG	hsa00053	Ascorbate and aldarate metabolism	1/73	30/8144	0.2371	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04625	C-type lectin receptor signaling pathway	2/73	104/8144	0.239	0.8498	0.8498	IL2/SYK	2
KEGG	hsa04613	Neutrophil extracellular trap formation	3/73	190/8144	0.2423	0.8498	0.8498	CTSG/HDAC9/SYK	3
KEGG	hsa00410	beta-Alanine metabolism	1/73	31/8144	0.2439	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04215	Apoptosis - multiple species	1/73	32/8144	0.2507	0.8498	0.8498	PMAIP1	1
KEGG	hsa04659	Th17 cell differentiation	2/73	108/8144	0.2523	0.8498	0.8498	IL2/IL2RB	2
KEGG	hsa04670	Leukocyte transendothelial migration	2/73	114/8144	0.2723	0.8498	0.8498	ACTN1/CLDN20	2
KEGG	hsa00350	Tyrosine metabolism	1/73	36/8144	0.2774	0.8498	0.8498	TYR	1
KEGG	hsa03030	DNA replication	1/73	36/8144	0.2774	0.8498	0.8498	RNASEH2B	1
KEGG	hsa04960	Aldosterone-regulated sodium reabsorption	1/73	37/8144	0.2839	0.8498	0.8498	IRS1	1
KEGG	hsa05216	Thyroid cancer	1/73	37/8144	0.2839	0.8498	0.8498	GADD45G	1
KEGG	hsa05330	Allograft rejection	1/73	38/8144	0.2903	0.8498	0.8498	IL2	1
KEGG	hsa00260	Glycine, serine and threonine metabolism	1/73	40/8144	0.303	0.8498	0.8498	ALDH7A1	1
KEGG	hsa03440	Homologous recombination	1/73	41/8144	0.3093	0.8498	0.8498	RAD54B	1
KEGG	hsa05219	Bladder cancer	1/73	41/8144	0.3093	0.8498	0.8498	DAPK2	1
KEGG	hsa04810	Regulation of actin cytoskeleton	3/73	218/8144	0.3106	0.8498	0.8498	ACTN1/ARHGEF6/INSRR	3
KEGG	hsa00380	Tryptophan metabolism	1/73	42/8144	0.3155	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04380	Osteoclast differentiation	2/73	128/8144	0.3189	0.8498	0.8498	IL1A/SYK	2
KEGG	hsa00071	Fatty acid degradation	1/73	43/8144	0.3217	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04930	Type II diabetes mellitus	1/73	46/8144	0.3399	0.8498	0.8498	IRS1	1
KEGG	hsa04210	Apoptosis	2/73	136/8144	0.3452	0.8498	0.8498	GADD45G/PMAIP1	2
KEGG	hsa05322	Systemic lupus erythematosus	2/73	136/8144	0.3452	0.8498	0.8498	CTSG/ACTN1	2
KEGG	hsa00620	Pyruvate metabolism	1/73	47/8144	0.3458	0.8498	0.8498	ALDH7A1	1
KEGG	hsa00280	Valine, leucine and isoleucine degradation	1/73	48/8144	0.3517	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04672	Intestinal immune network for IgA production	1/73	49/8144	0.3576	0.8498	0.8498	IL2	1
KEGG	hsa04140	Autophagy - animal	2/73	141/8144	0.3615	0.8498	0.8498	IRS1/DAPK2	2
KEGG	hsa00330	Arginine and proline metabolism	1/73	51/8144	0.3691	0.8498	0.8498	ALDH7A1	1
KEGG	hsa05320	Autoimmune thyroid disease	1/73	53/8144	0.3804	0.8498	0.8498	IL2	1
KEGG	hsa05224	Breast cancer	2/73	147/8144	0.3809	0.8498	0.8498	FZD6/GADD45G	2
KEGG	hsa05226	Gastric cancer	2/73	149/8144	0.3873	0.8498	0.8498	FZD6/GADD45G	2
KEGG	hsa04923	Regulation of lipolysis in adipocytes	1/73	56/8144	0.3971	0.8498	0.8498	IRS1	1
KEGG	hsa04932	Non-alcoholic fatty liver disease	2/73	155/8144	0.4064	0.8498	0.8498	IRS1/IL1A	2
KEGG	hsa05213	Endometrial cancer	1/73	58/8144	0.4079	0.8498	0.8498	GADD45G	1
KEGG	hsa04150	mTOR signaling pathway	2/73	156/8144	0.4095	0.8498	0.8498	FZD6/IRS1	2
KEGG	hsa04218	Cellular senescence	2/73	156/8144	0.4095	0.8498	0.8498	IL1A/GADD45G	2
KEGG	hsa00561	Glycerolipid metabolism	1/73	61/8144	0.4238	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04213	Longevity regulating pathway - multiple species	1/73	62/8144	0.429	0.8498	0.8498	IRS1	1
KEGG	hsa00310	Lysine degradation	1/73	63/8144	0.4342	0.8498	0.8498	ALDH7A1	1
KEGG	hsa03250	Viral life cycle - HIV-1	1/73	63/8144	0.4342	0.8498	0.8498	ELL2	1
KEGG	hsa04929	GnRH secretion	1/73	64/8144	0.4393	0.8498	0.8498	GNRH1	1
KEGG	hsa04310	Wnt signaling pathway	2/73	167/8144	0.4436	0.8498	0.8498	FZD6/LGR6	2
KEGG	hsa05225	Hepatocellular carcinoma	2/73	168/8144	0.4466	0.8498	0.8498	FZD6/GADD45G	2
KEGG	hsa00010	Glycolysis / Gluconeogenesis	1/73	67/8144	0.4543	0.8498	0.8498	ALDH7A1	1
KEGG	hsa04664	Fc epsilon RI signaling pathway	1/73	68/8144	0.4593	0.8498	0.8498	SYK	1
KEGG	hsa04920	Adipocytokine signaling pathway	1/73	69/8144	0.4642	0.8498	0.8498	IRS1	1
KEGG	hsa04520	Adherens junction	1/73	71/8144	0.4738	0.8498	0.8498	ACTN1	1
KEGG	hsa04137	Mitophagy - animal	1/73	72/8144	0.4786	0.8498	0.8498	RHOT1	1
KEGG	hsa05218	Melanoma	1/73	72/8144	0.4786	0.8498	0.8498	GADD45G	1
KEGG	hsa05223	Non-small cell lung cancer	1/73	72/8144	0.4786	0.8498	0.8498	GADD45G	1
KEGG	hsa00562	Inositol phosphate metabolism	1/73	73/8144	0.4833	0.8498	0.8498	PIK3C2A	1
KEGG	hsa01524	Platinum drug resistance	1/73	73/8144	0.4833	0.8498	0.8498	PMAIP1	1
KEGG	hsa04360	Axon guidance	2/73	182/8144	0.4883	0.8498	0.8498	PLXNB1/SRGAP2	2
KEGG	hsa03320	PPAR signaling pathway	1/73	75/8144	0.4926	0.8498	0.8498	ACOX2	1
KEGG	hsa05214	Glioma	1/73	75/8144	0.4926	0.8498	0.8498	GADD45G	1
KEGG	hsa04010	MAPK signaling pathway	3/73	294/8144	0.494	0.8498	0.8498	TEK/IL1A/GADD45G	3
KEGG	hsa04971	Gastric acid secretion	1/73	76/8144	0.4972	0.8498	0.8498	KCNJ15	1
KEGG	hsa05133	Pertussis	1/73	76/8144	0.4972	0.8498	0.8498	IL1A	1
KEGG	hsa05220	Chronic myeloid leukemia	1/73	76/8144	0.4972	0.8498	0.8498	GADD45G	1
KEGG	hsa05140	Leishmaniasis	1/73	77/8144	0.5017	0.8498	0.8498	IL1A	1
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/73	77/8144	0.5017	0.8498	0.8498	DSG2	1
KEGG	hsa00983	Drug metabolism - other enzymes	1/73	80/8144	0.5151	0.8498	0.8498	XDH	1
KEGG	hsa04662	B cell receptor signaling pathway	1/73	82/8144	0.5239	0.8498	0.8498	SYK	1
KEGG	hsa01232	Nucleotide metabolism	1/73	85/8144	0.5367	0.8498	0.8498	XDH	1
KEGG	hsa04742	Taste transduction	1/73	86/8144	0.5409	0.8498	0.8498	TAS2R30	1
KEGG	hsa04510	Focal adhesion	2/73	201/8144	0.5417	0.8498	0.8498	COL9A1/ACTN1	2
KEGG	hsa05169	Epstein-Barr virus infection	2/73	202/8144	0.5444	0.8498	0.8498	GADD45G/SYK	2
KEGG	hsa04512	ECM-receptor interaction	1/73	88/8144	0.5492	0.8498	0.8498	COL9A1	1
KEGG	hsa05205	Proteoglycans in cancer	2/73	205/8144	0.5525	0.8498	0.8498	FZD6/TIMP3	2
KEGG	hsa04211	Longevity regulating pathway	1/73	89/8144	0.5532	0.8498	0.8498	IRS1	1
KEGG	hsa04740	Olfactory transduction	4/73	440/8144	0.5615	0.8498	0.8498	OR52E4/OR56B1/OR10AD1/OR2T3	4
KEGG	hsa05222	Small cell lung cancer	1/73	92/8144	0.5653	0.8498	0.8498	GADD45G	1
KEGG	hsa04912	GnRH signaling pathway	1/73	93/8144	0.5692	0.8498	0.8498	GNRH1	1
KEGG	hsa04970	Salivary secretion	1/73	93/8144	0.5692	0.8498	0.8498	MUC7	1
KEGG	hsa03015	mRNA surveillance pathway	1/73	97/8144	0.5846	0.8498	0.8498	GSPT1	1
KEGG	hsa04070	Phosphatidylinositol signaling system	1/73	97/8144	0.5846	0.8498	0.8498	PIK3C2A	1
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	1/73	97/8144	0.5846	0.8498	0.8498	SYK	1
KEGG	hsa05215	Prostate cancer	1/73	97/8144	0.5846	0.8498	0.8498	INSRR	1
KEGG	hsa00564	Glycerophospholipid metabolism	1/73	98/8144	0.5884	0.8498	0.8498	ETNK1	1
KEGG	hsa04640	Hematopoietic cell lineage	1/73	99/8144	0.5921	0.8498	0.8498	IL1A	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	1/73	100/8144	0.5958	0.8498	0.8498	IL1A	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	2/73	222/8144	0.5962	0.8498	0.8498	IL2/IL2RB	2
KEGG	hsa05142	Chagas disease	1/73	102/8144	0.6031	0.8498	0.8498	IL2	1
KEGG	hsa04660	T cell receptor signaling pathway	1/73	104/8144	0.6103	0.8498	0.8498	IL2	1
KEGG	hsa05171	Coronavirus disease - COVID-19	2/73	232/8144	0.6204	0.8498	0.8498	IL2/SYK	2
KEGG	hsa03013	Nucleocytoplasmic transport	1/73	108/8144	0.6243	0.8498	0.8498	RANBP17	1
KEGG	hsa04931	Insulin resistance	1/73	108/8144	0.6243	0.8498	0.8498	IRS1	1
KEGG	hsa04066	HIF-1 signaling pathway	1/73	109/8144	0.6277	0.8498	0.8498	TEK	1
KEGG	hsa04725	Cholinergic synapse	1/73	113/8144	0.641	0.8498	0.8498	CHRNA3	1
KEGG	hsa01200	Carbon metabolism	1/73	115/8144	0.6475	0.8498	0.8498	ESD	1
KEGG	hsa04726	Serotonergic synapse	1/73	115/8144	0.6475	0.8498	0.8498	KCND2	1
KEGG	hsa05131	Shigellosis	2/73	247/8144	0.6547	0.8498	0.8498	ACTN1/U2AF1L4	2
KEGG	hsa05168	Herpes simplex virus 1 infection	4/73	495/8144	0.6558	0.8498	0.8498	CD74/SYK/ZNF479/ZNF714	4
KEGG	hsa04722	Neurotrophin signaling pathway	1/73	119/8144	0.6602	0.8498	0.8498	IRS1	1
KEGG	hsa04935	Growth hormone synthesis, secretion and action	1/73	119/8144	0.6602	0.8498	0.8498	IRS1	1
KEGG	hsa04152	AMPK signaling pathway	1/73	120/8144	0.6633	0.8498	0.8498	IRS1	1
KEGG	hsa04611	Platelet activation	1/73	124/8144	0.6754	0.8529	0.8529	SYK	1
KEGG	hsa05010	Alzheimer disease	3/73	384/8144	0.6761	0.8529	0.8529	FZD6/IRS1/IL1A	3
KEGG	hsa04110	Cell cycle	1/73	126/8144	0.6813	0.8529	0.8529	GADD45G	1
KEGG	hsa00230	Purine metabolism	1/73	128/8144	0.687	0.8536	0.8536	XDH	1
KEGG	hsa04142	Lysosome	1/73	132/8144	0.6983	0.8567	0.8567	CTSG	1
KEGG	hsa04910	Insulin signaling pathway	1/73	137/8144	0.7118	0.8567	0.8567	IRS1	1
KEGG	hsa05135	Yersinia infection	1/73	137/8144	0.7118	0.8567	0.8567	IL2	1
KEGG	hsa05418	Fluid shear stress and atherosclerosis	1/73	139/8144	0.717	0.8567	0.8567	IL1A	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	1/73	142/8144	0.7247	0.8567	0.8567	UBE2QL1	1
KEGG	hsa04936	Alcoholic liver disease	1/73	142/8144	0.7247	0.8567	0.8567	ALDH7A1	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	1/73	143/8144	0.7272	0.8567	0.8567	FZD6	1
KEGG	hsa03040	Spliceosome	1/73	147/8144	0.737	0.8567	0.8567	U2AF1L4	1
KEGG	hsa04072	Phospholipase D signaling pathway	1/73	148/8144	0.7394	0.8567	0.8567	SYK	1
KEGG	hsa04514	Cell adhesion molecules	1/73	149/8144	0.7418	0.8567	0.8567	CLDN20	1
KEGG	hsa04934	Cushing syndrome	1/73	155/8144	0.7556	0.8587	0.8587	FZD6	1
KEGG	hsa04390	Hippo signaling pathway	1/73	157/8144	0.7601	0.8587	0.8587	FZD6	1
KEGG	hsa05160	Hepatitis C	1/73	157/8144	0.7601	0.8587	0.8587	CLDN20	1
KEGG	hsa04217	Necroptosis	1/73	159/8144	0.7644	0.8587	0.8587	IL1A	1
KEGG	hsa04022	cGMP-PKG signaling pathway	1/73	167/8144	0.7811	0.8715	0.8715	IRS1	1
KEGG	hsa05164	Influenza A	1/73	171/8144	0.789	0.8743	0.8743	IL1A	1
KEGG	hsa05165	Human papillomavirus infection	2/73	331/8144	0.8034	0.8843	0.8843	FZD6/COL9A1	2
KEGG	hsa04621	NOD-like receptor signaling pathway	1/73	184/8144	0.8128	0.8881	0.8881	NLRP7	1
KEGG	hsa05034	Alcoholism	1/73	187/8144	0.8179	0.8881	0.8881	HDAC9	1
KEGG	hsa04062	Chemokine signaling pathway	1/73	192/8144	0.8261	0.8881	0.8881	CCL21	1
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	1/73	194/8144	0.8293	0.8881	0.8881	SYK	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	1/73	197/8144	0.834	0.8881	0.8881	CLDN20	1
KEGG	hsa05415	Diabetic cardiomyopathy	1/73	203/8144	0.8429	0.8919	0.8919	IRS1	1
KEGG	hsa04015	Rap1 signaling pathway	1/73	210/8144	0.8528	0.8936	0.8936	TEK	1
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	1/73	212/8144	0.8555	0.8936	0.8936	CHRNA3	1
KEGG	hsa04024	cAMP signaling pathway	1/73	221/8144	0.867	0.8999	0.8999	SOX9	1
KEGG	hsa04014	Ras signaling pathway	1/73	232/8144	0.8799	0.9019	0.9019	TEK	1
KEGG	hsa04714	Thermogenesis	1/73	232/8144	0.8799	0.9019	0.9019	KLB	1
KEGG	hsa05132	Salmonella infection	1/73	249/8144	0.8974	0.9104	0.9104	PIK3C2A	1
KEGG	hsa04144	Endocytosis	1/73	251/8144	0.8993	0.9104	0.9104	IL2RB	1
KEGG	hsa05020	Prion disease	1/73	273/8144	0.9179	0.9236	0.9236	IL1A	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	2/73	476/8144	0.9327	0.9327	0.9327	FZD6/IL1A	2